Anti-HBV transfer factor (Wuhan Hiteck Bio-pharmaceutical)

抗乙型肝炎转移因子

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-HBV transfer factor (Wuhan Hiteck Bio-pharmaceutical)
Drug Alias Name奥肝肽Oligotide
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract > Animal extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Hiteck Biological Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Hiteck Biological Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AX
Related LinksN/A